UPDATED: EU authorises Pfizer/BioNTech's COVID-19 vaccine

Authorisation closely follows CHMP recommendation. The European Commission has granted Pfizer/BioNTech's COVID-19 vaccine a conditional market authorisation (CMA) on the same day that the European Medicines Agency's ... Under the CMA process, the

Moderna eyes COVID-19 vaccine approval in the US and the EU

The company is also set to apply for a Conditional Marketing Authorisation (CMA) application with the European Medicines Agency (EMA), priming itself to score regulatory approval for the vaccine on both

Roche to close $4.3bn Spark deal after FTC clearance

The main concern posed by the CMA and the FTC is that the newly merged company could have an overly dominant position in the haemophilia A market. ... The FTC and CMA investigation into the merger was a surprise for not only Spark, but the entire pharma

UK’s CMA clears Roche’s $4.3bn takeover of Spark

Roche first announced its intention to acquire Spark in February, but has had to keep pushing back the completion date as the FTC in the US and the CMA in the ... In a statement from the CMA, the antitrust authority said: “While gene therapy treatments

Pfizer, Flynn face reinstatement of £90m CMA fine

The case dates back to 2015, when the Competition and Markets Authority (CMA)   accused the two companies of dramatically raising the price of phenytoin sodium, a drug that has been used ... A  report in the Financial Times says the CMA is arguing

Strengthening business competition and reducing anti-competitive practices

A firm pharma focus. The CMA’s focus on the pharmaceutical industry is not surprising. ... cartel activities and serious abuses of a dominant position, which the CMA categorises.

Five things you didn't realise you already know about influencer marketing

The Advertising Standards Authority (ASA) and Competitions and Markets Authority (CMA) have been applying stricter guidelines and monitoring the industry more closely. ... Always seek advice from the agency you’re working with or directly from the ASA

Stakeholder dialogue in Europe’s adaptive pathways pilot

The use of real-world evidence (RWE) as a complement to clinical trial data to support reimbursement decisions after Conditional Marketing Authorisation (CMA) is granted.

Drug pricing

Healthcare systems